Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
MedTech
MedTech
Industry at a ‘turning point’ with growth dominated by leaders
In 2025 through the first half of 2026, innovation increased dealmaking and R&D investment as AI heavily influenced the future of value creation.
Patrick McGuire
Oct 20, 2026 7:43am
AstraZeneca taps Oracle to improve recruitment for trials
Oct 20, 2026 2:36am
Lilly allies with Metis in $1.1B AI nanoparticle discovery deal
Oct 19, 2026 10:45am
Siemens Healthineers partners with Paradromics to support BCIs
Oct 19, 2026 8:00am
Labcorp pays $722M in upfront deal for BioReference assets
Oct 18, 2026 8:23am
SimBioSys nabs FDA OK for AI breast cancer recurrence tool
Oct 16, 2026 9:00am
